Enhanced Saline-Based Nasal Treatment Composition

Publication ID: 24-11857569_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Saline-Based Nasal Treatment Composition,” Published Technical Disclosure No. 24-11857569_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857569_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,569.

Summary of the Inventive Concept

An improved nasal cleansing composition with optimized pH levels, enhanced gelling properties, and added analgesic and antimicrobial components for better efficacy, comfort, and safety.

Background and Problem Solved

The original saline-based nasal treatment composition had limitations in terms of pH level, gelling properties, and lack of analgesic and antimicrobial components, leading to potential irritation, infection, and discomfort. The new inventive concept addresses these limitations by incorporating a pH-adjusted saline solution, a gelling component that forms a protective barrier, an added analgesic component for rapid pain relief, and an antimicrobial component for reduced contamination risk.

Detailed Description of the Inventive Concept

The enhanced saline-based nasal treatment composition comprises a saline solution with a pH level adjusted to match the natural pH of the nasal cavity, thereby reducing irritation and improving efficacy. The composition also includes a gelling component that forms a protective barrier on the nasal mucosa, reducing the risk of infection. Additionally, an analgesic component is added to provide rapid pain relief, and an antimicrobial component is included to reduce the risk of contamination during use. The surfactant component is optimized to enhance the solubility of the saline solution, improving its ability to remove allergens and debris from the nasal cavity.

Novelty and Inventive Step

The new claims introduce novel features such as pH-adjusted saline solutions, gelling components that form protective barriers, added analgesic components, and antimicrobial components, which are not present in the original patent. These features provide a significant improvement in efficacy, comfort, and safety, making the new inventive concept non-obvious and novel compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the concentration of the analgesic component, using different types of gelling agents, or incorporating additional natural extracts for enhanced soothing properties. Variations could also include different packaging and delivery systems, such as nasal sprays or drops, to cater to different user preferences.

Potential Commercial Applications and Market

The enhanced saline-based nasal treatment composition has significant commercial potential in the healthcare industry, particularly in the nasal care and allergy relief markets. The product could be marketed as a premium, high-efficacy nasal cleansing solution for individuals seeking improved comfort, safety, and relief from nasal congestion and allergies.

Original Patent Information

Patent NumberUS 11,857,569
TitleSaline-based nasal treatment composition
Assignee(s)Joonem LLC